Mouse models of dengue virus infection and disease

被引:128
作者
Yauch, Lauren E. [1 ]
Shresta, Sujan [1 ]
机构
[1] La Jolla Inst Allergy & Immunol, Div Vaccine Discovery, La Jolla, CA 92037 USA
关键词
Flavivirus; Dengue virus; Mouse model; Vaccine; Antiviral therapy; Dengue fever; Dengue hemorrhagic fever/dengue shock syndrome;
D O I
10.1016/j.antiviral.2008.06.010
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Dengue virus (DENV) causes the most significant mosquito-borne viral disease in the world in terms of illness, death, and economic cost, due to the lack of an approved vaccine or antiviral. Infections with one of the four serotypes of DENV (DENV1-4) can result in diseases ranging from an acute, self-limiting febrile illness (dengue fever, DF) to life-threatening dengue hemorrhagic fever (DHF) or dengue shock syndrome (DSS), yet exactly how viral and host factors contribute to the severe disease is unknown. Clinical observations have provided information on DENV pathogenesis, but the lack of an adequate animal model has hindered research on this important human pathogen. A mouse model is ideal for investigating host-pathogen interactions due to the immunological tools available, however, wild-type mice are resistant to DENV-induced disease. Therefore, the mouse models for DENV infection developed to date include infection of severely immunocompromised mice, non-physiologic routes of infection, and mouse-human chimeras. which all have their limitations. An inbred mouse model in which mice develop signs of human DENV-induced disease is needed to investigate the contribution of various immune components to protection and pathogenesis of DENV infections, and to test the efficacy of DENV vaccines and antivirals. (C) 2008 Elsevier B.V. All rights reserved
引用
收藏
页码:87 / 93
页数:7
相关论文
共 81 条
[1]   Development of a novel mouse model for dengue virus infection [J].
An, J ;
Kimura-Kuroda, J ;
Hirabayashi, Y ;
Yasui, K .
VIROLOGY, 1999, 263 (01) :70-77
[2]   Cross-reactive memory CD8+ T cells alter the immune response to heterologous secondary dengue virus infections in mice in a sequence-specific manner [J].
Beaumier, Coreen M. ;
Mathew, Anuja ;
Bashyam, Hema S. ;
Rothman, Alan L. .
JOURNAL OF INFECTIOUS DISEASES, 2008, 197 (04) :608-617
[3]   Dengue fever in humanized NOD/SCID mice [J].
Bente, DA ;
Melkus, MW ;
Garcia, JV ;
Rico-Hesse, R .
JOURNAL OF VIROLOGY, 2005, 79 (21) :13797-13799
[4]   Genetic basis of attenuation of Dengue virus type 4 small plaque mutants with restricted replication in suckling mice and in SCID mice transplanted with human liver cells [J].
Blaney, JE ;
Johnson, DH ;
Manipon, GG ;
Firestone, CY ;
Hanson, CT ;
Murphy, BR ;
Whitehead, SS .
VIROLOGY, 2002, 300 (01) :125-139
[5]   Recombinant, live-attenuated tetravalent dengue virus vaccine formulations induce a balanced, broad, and protective neutralizing antibody response against each of the four serotypes in rhesus monkeys [J].
Blaney, JE ;
Matro, JM ;
Murphy, BR ;
Whitehead, SS .
JOURNAL OF VIROLOGY, 2005, 79 (09) :5516-5528
[6]   MICE IMMUNIZED WITH RECOMBINANT VACCINIA VIRUS EXPRESSING DENGUE-4 VIRUS STRUCTURAL PROTEINS WITH OR WITHOUT NONSTRUCTURAL PROTEIN-NS1 ARE PROTECTED AGAINST FATAL DENGUE VIRUS ENCEPHALITIS [J].
BRAY, M ;
ZHAO, BT ;
MARKOFF, L ;
ECKELS, KH ;
CHANOCK, RM ;
LAI, CJ .
JOURNAL OF VIROLOGY, 1989, 63 (06) :2853-2856
[7]   A PROSPECTIVE-STUDY OF DENGUE INFECTIONS IN BANGKOK [J].
BURKE, DS ;
NISALAK, A ;
JOHNSON, DE ;
SCOTT, RM .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1988, 38 (01) :172-180
[8]   Non-structural proteins of dengue 2 virus offer limited protection to interferon-deficient mice after dengue 2 virus challenge [J].
Calvert, AE ;
Huang, CYH ;
Kinney, RM ;
Roehrig, JT .
JOURNAL OF GENERAL VIROLOGY, 2006, 87 :339-346
[9]   FLAVIVIRUS GENOME ORGANIZATION, EXPRESSION, AND REPLICATION [J].
CHAMBERS, TJ ;
HAHN, CS ;
GALLER, R ;
RICE, CM .
ANNUAL REVIEW OF MICROBIOLOGY, 1990, 44 :649-688
[10]   Lymphocyte activation and hepatic cellular infiltration in immunocompetent mice infected by dengue virus [J].
Chen, HC ;
Lai, SY ;
Sung, JM ;
Lee, SH ;
Lin, YC ;
Wang, WK ;
Chen, YC ;
Kao, CL ;
King, CC ;
Wu-Hsieh, BA .
JOURNAL OF MEDICAL VIROLOGY, 2004, 73 (03) :419-431